Q1 2026 Holdings
Filed 2026-05-15 | 50 holdings | $499.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $102.8M | 628,712 | 20.6% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $66.9M | 600,747 | 13.4% |
| Insmed Inc(INSM)Put | COM PAR $.01 | 457669307 | $45.7M | 279,700 | 9.2% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $35.2M | 38,220 | 7.0% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $24.0M | 2,013,602 | 4.8% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $21.7M | 29,739 | 4.3% |
| Astrazeneca PLC(AZN) | ORD | G0593M107 | $18.8M | 95,376 | 3.8% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $16.1M | 503,936 | 3.2% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $13.7M | 162,990 | 2.7% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $12.2M | 124,990 | 2.4% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $10.8M | 144,376 | 2.2% |
| Moderna Inc(MRNA)Call | COM | 60770K107 | $10.2M | 200,000 | 2.0% |
| Eyepoint Inc(EYPT) | COM NEW | 30233G209 | $9.9M | 767,098 | 2.0% |
| Quest Diagnostics Inc(DGX) | COM | 74834L100 | $8.0M | 40,817 | 1.6% |
| Alumis Inc(ALMS) | COM | 022307102 | $7.2M | 325,046 | 1.4% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $5.9M | 180,731 | 1.2% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $5.6M | 46,700 | 1.1% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $5.5M | 104,800 | 1.1% |
| Johnson & Johnson(JNJ) | COM | 478160104 | $5.5M | 22,600 | 1.1% |
| Sionna Therapeutics Inc(SION) | COM | 829401108 | $4.8M | 119,741 | 1.0% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $4.7M | 96,285 | 0.9% |
| Rapport Therapeutics Inc(RAPP) | COM | 75383L102 | $4.3M | 138,508 | 0.9% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $4.1M | 17,740 | 0.8% |
| Belite BIO Inc(BLTE) | SPONSORED ADS | 07782B104 | $4.0M | 24,989 | 0.8% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $3.8M | 65,000 | 0.8% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $3.7M | 137,800 | 0.7% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $3.6M | 129,800 | 0.7% |
| Palisade BIO Inc(PALI) | COM | 696389402 | $3.5M | 1,992,367 | 0.7% |
| Biogen Inc(BIIB) | COM | 09062X103 | $3.4M | 18,437 | 0.7% |
| Prokidney Corp(PROK) | SHS CL A | 74291D104 | $3.2M | 1,806,939 | 0.6% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $3.2M | 14,500 | 0.6% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $3.0M | 5,000 | 0.6% |
| Bright Minds Biosciences Inc(DRUG) | COM NEW | 10919W405 | $2.8M | 38,407 | 0.6% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $2.4M | 22,931 | 0.5% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $2.3M | 68,490 | 0.5% |
| Brightspring Health Svcs Inc(BTSG) | COM | 10950A106 | $2.3M | 53,800 | 0.5% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $2.1M | 70,700 | 0.4% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $2.1M | 65,500 | 0.4% |
| Celcuity Inc(CELC) | COM | 15102K100 | $1.8M | 15,576 | 0.4% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $1.5M | 20,400 | 0.3% |
| Kiniksa Pharmaceuticals Intl(KNSA) | ORD SHS CL A | G52694109 | $1.4M | 29,200 | 0.3% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $1.1M | 16,300 | 0.2% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $819.3K | 20,900 | 0.2% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $805.5K | 2,500 | 0.2% |
| Tenax Therapeutics Inc(TENX) | COM NEW | 88032L605 | $672.9K | 42,080 | 0.1% |
| Kodiak Sciences Inc(KOD) | COM | 50015M109 | $648.8K | 17,019 | 0.1% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $502.0K | 4,900 | 0.1% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $495.4K | 5,886 | 0.1% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $432.5K | 28,970 | 0.1% |
| Pepgen Inc(PEPG) | COM | 713317105 | $363.4K | 205,324 | 0.1% |